- Home
- / EUROAPI
EUROAPI
Stock Price
€3.6
2024-10-29
Market Capitalization
€341 M
2024-10-29
Revenue
€848.2 M
FY, 2025
EUROAPI Summary
Company Summary
- Overview
- EUROAPI is a manufacturer and supplier of active pharmaceutical ingredients (APIs). It offers vitamin B12, prostaglandins, corticoids and hormones, opiates and controlled substances, anti-infectives, and small and complex molecules.
- Type
- Public
- Status
- Active
- Founded
- 2020
- HQ
- Paris, FR | view all locations
- Website
- https://www.euroapi.com/en
- Cybersecurity rating
Table of Contents
Key People
Antoine Delcour, Chief Financial Officer
David Seignolle, Chief Operating Officer
Guillaume Rosso, Chief Strategy and M&A Officer
Operating MetricsView all
Services Provided
7
Nov, 2022
Production Sites
6
Nov, 2022
Solutions
200
Nov, 2022
LocationsView all
1 location detected
Paris, IDF HQ
France
15 Rue Traversière
EUROAPI Financials
Summary Financials
- Revenue (FY, 2025)
- €848.2M
- Gross profit (FY, 2025)
- €208.8M
- Net income (FY, 2025)
- (€211.1M)
- Cash (FY, 2025)
- €113.8M
- EBIT (FY, 2025)
- (€136.3M)
- Enterprise value
- $292.6M